The need for resilient and adaptable supply chains has never been more apparent. Parsyl strengthens critical global cold chains with modern, end-to-end temperature monitoring and data-powered cargo insurance, protecting health commodities from the first mile to the last.
In partnership with Gavi, the Vaccine Alliance, Parsyl monitors vaccine cold chains around the world. In 2018, Senegal’s Ministry of Health (MoH) engaged Parsyl to improve the country’s extensive vaccine supply chain. By placing Parsyl’s wireless sensors inside cold rooms, refrigerators and cold boxes that store and transport vaccines, MoH personnel and frontline workers have newfound visibility into the causes and location of possible vaccine degradation with alerts and notifications available via a user-friendly mobile app.
“ We found inefficiencies in vaccine stock and supplies which is why we implemented Parsyl. Users are now able to better protect the cold chain.”
Dr. Amy Lo Ndyaie, Logistics Coordinator, Ministry of Health, Senegal
Alerts via SMS and/or email notify workers of harmful conditions
Smart Countdown feature tracks remaining shelf life—including thawed ultra cold chain (UCC) vaccines
Data is collected and stored, even in remote health posts with low and no connectivity
Insights uncover cold chain equipment (CCE) malfunctions and opportunities to improve Expanded Program on Immunization (EPI) supervision and training practices
“ Our supply chain has improved thanks to Parsyl. We've been able to identify and replace certain cold chain equipment and improve best practices for storing vaccines within their recommended temperature ranges.”
Mor Diama, Vaccination Logistician, Ministry of Health, Senegal
Parsyl devices have been placed in national-level cold rooms and freezers across Senegal, notifying EPI logistics managers of temperature excursions. The decrease in temperature alarms over time has shown that data visibility has the power to positively impact cold chain management.
Parsyl will soon cover 100% of the country’s cold chain and is already monitoring COVAX vaccines in Senegal and several other African countries.
With this kind of coverage and data, countries will be better equipped to make the improvements necessary to ensure all people receive safe and potent vaccines.